Embracing you Inner Geezer

NHF (Orlando, July 21-23): Dr Barbara Konkle of Bloodworks NW and Dr. Bruce Hough of St. Joseph’s Children’s Hospital discussed haemophilia care in the aging population including issues of cardiovascular disease, hepatitis C, and liver cancer.

NHF (Orlando, July 21-23): As part of the older adult track at the National Hemophilia Foundation’s annual meeting, Dr Barbara Konkle of Bloodworks NW and Dr. Bruce Hough of St. Joseph’s Children’s Hospital discussed haemophilia care in the aging population including issues of cardiovascular disease, hepatitis C, and liver cancer. Dr Konkle provided general guidelines on the care of patients with hemophilia and cardiovascular disease. She described how cholesterol lowering drugs likely posed no risk specifically in patients with hemophilia. In contrast, patients who need to be on a low dose aspirin regimen may require at least some level of routine factor replacement (prophylaxis), while those on blood thinners (anticoagulants like heparin, warfarin/Coumadin, and newer agents) may require require factor levels greater than 30% to avoid bleeding complications. The great majority of questions from the audience focused on liver-related issues including access to hepatitis C treatment and the eligibility for liver transplants.